Actively Recruiting
A Clinical Study of B007 in the Treatment of Pemphigus.
Led by Shanghai Jiaolian Drug Research and Development Co., Ltd · Updated on 2026-05-05
132
Participants Needed
12
Research Sites
128 weeks
Total Duration
On this page
Sponsors
S
Shanghai Jiaolian Drug Research and Development Co., Ltd
Lead Sponsor
S
Shanghai Pharmaceuticals Holding Co., Ltd
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the efficacy and safety of B007 in subjects with pemphigus.
CONDITIONS
Official Title
A Clinical Study of B007 in the Treatment of Pemphigus.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Voluntarily agree to participate and sign informed consent
- Clinically diagnosed with pemphigus based on clinical signs
- Newly diagnosed or experiencing a relapse of pemphigus
- Able to follow the study protocol as judged by the investigator
You will not qualify if you...
- Diagnosed with pemphigus more than 4 years ago
- Currently using treatment drugs for pemphigus
- Have other specified diseases or medical history that disqualify participation
- Have examination abnormalities deemed unsuitable for the study by the investigator
- History of severe allergy or allergic reaction to human or mouse monoclonal antibodies
- Known contraindications to oral prescribed drugs
- Participated in another interventional clinical trial within a specified time before the study
- Received live vaccine within a specified time before first dose or expected to receive live vaccine shortly after last dose
- Pregnant or breastfeeding women
- Fertile women not agreeing to use effective contraception during and after the study
- Sexually active men not planning to use contraception or planning to donate sperm during or after the study
- Other conditions considered unsuitable for participation by the researchers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 12 locations
1
Peking University First Hospital
Beijing, China
Actively Recruiting
2
The Second Xiangya Hospital of Central South University
Changsha, China
Actively Recruiting
3
Chengdu Second People's Hospital
Chengdu, China
Actively Recruiting
4
West China Hospital, Sichuan University
Chengdu, China
Actively Recruiting
5
The First Affiliated Hospital of Chongqing Medical University
Chongqing, China
Actively Recruiting
6
The First Affiliated Hospital of Fujian Medical University
Fuzhou, China
Actively Recruiting
7
Dermatology Hospital of Southern Medical University
Guangzhou, China
Actively Recruiting
8
Guangdong Provincial People's Hospital
Guangzhou, China
Actively Recruiting
9
Shandong First Medical University-Affiliated Skin Hospital
Jinan, China
Actively Recruiting
10
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, China
Actively Recruiting
11
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China
Actively Recruiting
12
Henan Provincial People's Hospital
Zhengzhou, China
Actively Recruiting
Research Team
H
Hang Li
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here